76 related articles for article (PubMed ID: 18329790)
1. High-LET radiation combined with oxaliplatin induce autophagy in U-87 glioblastoma cells.
Benzina S; Altmeyer A; Malek F; Dufour P; Denis JM; Gueulette J; Bischoff P
Cancer Lett; 2008 Jun; 264(1):63-70. PubMed ID: 18329790
[TBL] [Abstract][Full Text] [Related]
2. The cytotoxicity of high-linear energy transfer radiation is reinforced by oxaliplatin in human glioblastoma cells.
Benzina S; Debomy F; Bergerat JP; Denis JM; Gueulette J; Dufour P; Bischoff P
Cancer Lett; 2007 Aug; 254(1):54-62. PubMed ID: 17383816
[TBL] [Abstract][Full Text] [Related]
3. Cell death after high-LET irradiation in orthotopic human hepatocellular carcinoma in vivo.
Altmeyer A; Ignat M; Denis JM; Messaddeq N; Gueulette J; Mutter D; Bischoff P
In Vivo; 2011; 25(1):1-9. PubMed ID: 21282728
[TBL] [Abstract][Full Text] [Related]
4. Cell death induced in a human glioblastoma cell line by p(65)+Be neutrons combined with cisplatin.
Benzina S; Fischer B; Miternique-Grosse A; Dufour P; Denis JM; Bergerat JP; Gueulette J; Bischoff P
Life Sci; 2006 Jul; 79(6):513-8. PubMed ID: 16516239
[TBL] [Abstract][Full Text] [Related]
5. Irradiation combined with SU5416: microvascular changes and growth delay in a human xenograft glioblastoma tumor line.
Schuuring J; Bussink J; Bernsen HJ; Peeters W; van Der Kogel AJ
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):529-34. PubMed ID: 15667976
[TBL] [Abstract][Full Text] [Related]
6. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
Ding ZB; Hui B; Shi YH; Zhou J; Peng YF; Gu CY; Yang H; Shi GM; Ke AW; Wang XY; Song K; Dai Z; Shen YH; Fan J
Clin Cancer Res; 2011 Oct; 17(19):6229-38. PubMed ID: 21825039
[TBL] [Abstract][Full Text] [Related]
7. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological enhancement of autophagy induced in a hepatocellular carcinoma cell line by high-LET radiation.
Altmeyer A; Jung AC; Ignat M; Benzina S; Denis JM; Gueulette J; Noël G; Mutter D; Bischoff P
Anticancer Res; 2010 Feb; 30(2):303-10. PubMed ID: 20332433
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin enhances the cytotoxicity of fast neutrons in a murine lymphoma cell line.
Fischer B; Benzina S; Ganansia-Leymarie V; Denis JM; Bergerat JP; Dufour P; Gueulette J; Bischoff P
Can J Physiol Pharmacol; 2004 Feb; 82(2):140-5. PubMed ID: 15052295
[TBL] [Abstract][Full Text] [Related]
10. Combination effects of SC144 and cytotoxic anticancer agents.
Oshima T; Cao X; Grande F; Yamada R; Garofalo A; Louie S; Neamati N
Anticancer Drugs; 2009 Jun; 20(5):312-20. PubMed ID: 19322070
[TBL] [Abstract][Full Text] [Related]
11. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
12. Micronucleus response of human glioblastoma and neuroblastoma cells toward low-LET photon and high-LET p(66)/Be neutron irradiation.
Akudugu JM; Slabbert JP; Roos WP; Böhm L
Am J Clin Oncol; 2003 Jun; 26(3):e1-6. PubMed ID: 12796609
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor activity of de novo designed small globular protein (SGP) in vivo.
Tsugu H; Onishi H; Fukushima T; Lee S
Anticancer Res; 2006; 26(6A):4043-6. PubMed ID: 17195455
[TBL] [Abstract][Full Text] [Related]
14. Necrosis is not induced by gadolinium neutron capture in glioblastoma multiforme cells.
Yasui L; Owens K
Int J Radiat Biol; 2012 Dec; 88(12):980-90. PubMed ID: 22849307
[TBL] [Abstract][Full Text] [Related]
15. Mammalian cells loaded with platinum-containing molecules are sensitized to fast atomic ions.
Usami N; Furusawa Y; Kobayashi K; Lacombe S; Reynaud-Angelin A; Sage E; Wu TD; Croisy A; Guerquin-Kern JL; Le Sech C
Int J Radiat Biol; 2008 Jul; 84(7):603-11. PubMed ID: 18661376
[TBL] [Abstract][Full Text] [Related]
16. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
Boyd M; Sorensen A; McCluskey AG; Mairs RJ
J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin.
Zhao S; Cai J; Bian H; Gui L; Zhao F
Cancer Invest; 2009 Jul; 27(6):636-40. PubMed ID: 19387877
[TBL] [Abstract][Full Text] [Related]
18. In vivo studies of a platinum(II) metallointercalator.
Fisher DM; Fenton RR; Aldrich-Wright JR
Chem Commun (Camb); 2008 Nov; (43):5613-5. PubMed ID: 18997969
[TBL] [Abstract][Full Text] [Related]
19. The mTOR inhibitor RAD001 augments radiation-induced growth inhibition in a hepatocellular carcinoma cell line by increasing autophagy.
Altmeyer A; Josset E; Denis JM; Gueulette J; Slabbert J; Mutter D; Noël G; Bischoff P
Int J Oncol; 2012 Oct; 41(4):1381-6. PubMed ID: 22895785
[TBL] [Abstract][Full Text] [Related]
20. New therapeutic possibilities of combined treatment of radiotherapy with oxaliplatin and its liposomal formulation, Lipoxal™, in rectal cancer using xenograft in nude mice.
Tippayamontri T; Kotb R; Sanche L; Paquette B
Anticancer Res; 2014 Oct; 34(10):5303-12. PubMed ID: 25275023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
